IMMUTEP ADR |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.74 USD | +5.79% |
|
+1.11% | +14.17% |
| 06-05 | Immutep Completes Stock Offering | MT |
| 06-03 | Immutep, Merck Collaborate on Trial for Lung Cancer Therapy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 51.12B | - | |||||
| 39.4B | ||||||
| 38.48B | ||||||
| 26.22B | ||||||
| 26.36B |
